Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Increase abstinence from illicit drugs among pregnant women — MICH‑11

Status: Little or no detectable change

  
Little or no detectable change
Learn more about our data release schedule

Most Recent Data:
94.4 percent (2018-19)

Target:
95.3 percent

Desired Direction:
Increase desired

Baseline:
93.0 percent of pregnant females aged 15 to 44 years reported abstaining from illicit drugs in the past 30 days in 2017-18

See detailed data for this objective

Increase abstinence from illicit drugs among pregnant women

Target-Setting Method
Percentage point improvement

Data Source:  National Survey on Drug Use and Health (NSDUH), SAMHSA

Learn more about data measurement for this objective

Summary

Using drugs like marijuana, cocaine, or heroin during pregnancy can lead to miscarriage, preterm birth, and low birth weight. It can also cause withdrawal symptoms in infants after birth. In addition, substance use disorders have been linked to maternal deaths. Screening pregnant women for drug use and referring them to treatment when needed can help women avoid using drugs during pregnancy.

Topics:  Pregnancy and Childbirth, Drug and Alcohol Use, Women

Workgroup: Maternal, Infant, and Child Health Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives